Key points are not available for this paper at this time.
Expert review guides probiotic use in GI disorders; leaves open need for strain-specific RCTs before broader adoption.
Guarner, Francisco MD (Chair, Spain); Khan, Aamir G. MD (Pakistan); Garisch, James MD (South Africa); Eliakim, Rami MD (Israel); Gangl, Alfred MD (Austria); Thomson, Alan MD (Canada); Krabshuis, Justus (France); Lemair, Ton MD (The Netherlands); Kaufmann, Pedro MD (Uruguay); de Paula, Juan Andres MD (Argentina); Fedorak, Richard MD (Canada); Shanahan, Fergus MD (Ireland); Sanders, Mary Ellen PhD (USA); Szajewska, Hania MD (Poland); Ramakrishna, Balakrishnan Siddartha MD (India); Karakan, Tarkan MD (Turkey); Kim, Nayoung MD (South Korea) Review Team Invited outside experts Author Information
No takes yet. Share an insight, caveat, or question.
Guarner et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: